Assuntos
Astrocitoma/metabolismo , Neoplasias Encefálicas/metabolismo , Ependimoma/metabolismo , Glioblastoma/metabolismo , Neoplasias Infratentoriais/metabolismo , Oligodendroglioma/metabolismo , Proteínas Oncogênicas/metabolismo , Astrocitoma/diagnóstico , Neoplasias Encefálicas/diagnóstico , Ependimoma/diagnóstico , Glioblastoma/diagnóstico , Glioma/diagnóstico , Glioma/metabolismo , Histonas/genética , Histonas/metabolismo , Humanos , Neoplasias Infratentoriais/diagnóstico , Oligodendroglioma/diagnóstico , Sensibilidade e EspecificidadeAssuntos
Glioma/genética , Glioma/patologia , Proteína Proto-Oncogênica N-Myc/genética , Neoplasias Supratentoriais/genética , Neoplasias Supratentoriais/patologia , Adolescente , Neoplasias do Tronco Encefálico/genética , Neoplasias do Tronco Encefálico/patologia , Criança , Pré-Escolar , Metilação de DNA , Feminino , Amplificação de Genes , Humanos , Lactente , MasculinoRESUMO
BACKGROUND: Long-term use of high-dose progestin is known to promote the development of meningioma. Atypical meningioma in a patient under progestin has not previously been reported. CASE REPORT: A 53-year-old right-handed woman presented with focal onset seizures, without impaired consciousness. Medical history featured endometriosis, treated successively by cyproterone acetate 25mg/day for 2 months then 50mg/day for 101 months, and chlormadinone acetate 5mg/day for 68 months then 10mg/day for 83 months. Brain MRI revealed multiple extra-axial lesions suggestive of left central meningioma associated with anterior skull base meningiomatosis. Surgical resection of the left central meningioma was achieved and progestin was withdrawn. Neuropathology diagnosed grade II atypical meningioma. Close clinical and imaging monitoring was implemented without adjuvant oncological treatment. At 25 months, imaging follow-up showed no recurrence of the left central meningioma and a significant regression of all other lesions, except for the right frontal lesion. CONCLUSIONS: Neurosurgeons should be aware of the possible aggressiveness of meningioma in patients under progestin, and particularly those treated by different types of progestin over a long period of time without interruption. This may require systematic close monitoring, to adapt neurosurgical management.
Assuntos
Meningioma/metabolismo , Progestinas/metabolismo , Neoplasias da Base do Crânio/metabolismo , Progressão da Doença , Feminino , Humanos , Imageamento por Ressonância Magnética , Meningioma/diagnóstico por imagem , Meningioma/cirurgia , Pessoa de Meia-Idade , Procedimentos Neurocirúrgicos , Progesterona/antagonistas & inibidores , Neoplasias da Base do Crânio/diagnóstico por imagem , Neoplasias da Base do Crânio/cirurgia , Resultado do TratamentoAssuntos
Neoplasias do Tronco Encefálico/genética , Glioma/genética , Histona Desmetilases com o Domínio Jumonji/genética , Proteína Proto-Oncogênica N-Myc/genética , Neoplasias do Tronco Encefálico/diagnóstico por imagem , Neoplasias do Tronco Encefálico/patologia , Criança , Pré-Escolar , Diagnóstico Diferencial , Feminino , Amplificação de Genes , Glioma/diagnóstico por imagem , Glioma/patologia , Humanos , Lactente , Masculino , Técnicas de Amplificação de Ácido Nucleico , Ponte/diagnóstico por imagem , Ponte/patologiaRESUMO
BACKGROUND AND PURPOSE: Embryonal tumors with multilayered rosettes, C19MC-altered, are brain tumors occurring in young children, which were clearly defined in the 2016 World Health Organization classification of central nervous system neoplasms. Our objective was to describe the multimodal imaging characteristics of this new entity. MATERIALS AND METHODS: We performed a retrospective monocentric review of embryonal brain tumors and looked for embryonal tumors with multilayered rosettes with confirmed C19MC alteration. We gathered morphologic imaging data, as well as DWI and PWI data (using arterial spin-labeling and DSC). RESULTS: We included 16 patients with a median age of 2 years 8 months. Tumors were both supratentorial (56%, 9/16) and infratentorial (44%, 7/16). Tumors were large (median diameter, 59 mm; interquartile range, 48-71 mm), with absent (75%, 12/16) or minimal (25%, 4/16) peritumoral edema. Enhancement was absent (20%, 3/15) or weak (73%, 11/15), whereas intratumoral macrovessels were frequently seen (94%, 15/16) and calcifications were present in 67% (10/15). Diffusion was always restricted, with a minimal ADC of 520 mm2/s (interquartile range, 495-540 mm2/s). Cerebral blood flow using arterial spin-labeling was low, with a maximal CBF of 43 mL/min/100 g (interquartile range, 33-55 mL/min/100 g 5). When available (3 patients), relative cerebral blood volume using DSC was high (range, 3.5-5.8). CONCLUSIONS: Embryonal tumors with multilayered rosettes, C19MC-altered, have characteristic imaging features that could help in the diagnosis of this rare tumor in young children.